| CASE CAPTION |
Carmignac Gestion, S.A. v. Perrigo Co. plc, et al.; First Manhattan Co. v. Perrigo Co. plc, et al.; Nationwide Mutual Funds, on behalf of its series Nationwide Geneva Mid Cap Growth and Nationwide S&P 500 Index Fund, et al. v. Perrigo Co. plc, et al.; Aberdeen Canada Funds – Global Equity Fund, a series of Aberdeen Canada Funds, et al. v. Perrigo Co. plc, et al.; Schwab Capital Trust on behalf of its series Schwab S&P 500 Index Fund, Schwab Total Stock Market Index Fund, Schwab Fundamental U.S. Large Company Index Fund, and Schwab Health Care Fund, et al. v. Perrigo Co. plc, et al.; Principal Funds, Inc., et al. v. Perrigo Co. plc, et al.; and Kuwait Investment Authority, et al. v. Perrigo Co. plc, et al. |
| COURT |
United States District Court for the District of New Jersey |
| CASE NUMBER |
No. 2:17-cv-10467-MCA-LDW; No. 2:18-cv-02291-MCA-LDW; No. 2:18-cv-15382-MCA-LDW; No. 2:19-cv-06560-MCA-LDW; No. 2:19-cv-03973-MCA-LDW; No. 2:20-cv-02410-MCA-LDW; No. 2:20-cv-03431-MCA-LDW |
| JUDGE |
Honorable Madeline Cox Arleo and Honorable Leda Dunn Wettre |
| PLAINTIFFS |
Carmignac Gestion, S.A., First Manhattan Co., Schwab Capital Trust, et al., Principal Funds, Inc., Kuwait Investment Authority, et al., Nationwide Mutual Funds, et al., and Aberdeen Canada Funds – Global Equity Fund, et al.
|
| DEFENDANTS |
Perrigo Company plc (“Perrigo”), Joseph C. Papa, and Judy L. Brown |
| CLASS PERIOD |
April 21, 2015 through May 3, 2017, inclusive |
These seven shareholder opt-out actions stem from drug maker Perrigo’s efforts to mislead investors to stave off a hostile takeover bid by pharmaceutical rival Mylan in 2015. The plaintiff investment funds allege that Perrigo and its senior officers misrepresented the true state of the company’s $4.5 billion acquisition of Omega Pharma, an over-the-counter healthcare company based in Belgium, and fraudulently touted its ability to withstand pricing pressure from the influx of competing drugs in the generic drug markets.
In 2018, we filed the first of these actions in the United States District Court for the District of New Jersey on behalf of institutional investors in the United States, the United Kingdom, France, and Kuwait. The Honorable Madeline Cox Arleo denied Defendants’ motions to dismiss the actions in 2019. The parties concluded discovery in November 2021 and are awaiting summary judgment motion practice.
Read Charles Schwab v. Perrigo Amended Complaint Here
Read First Manhattan v. Perrigo Amended Complaint Here
Read First Manhattan v. Perrigo Motion to Dismiss Opinion Here
Read Kuwait v. Perrigo Complaint Here
Read Nationwide v. Perrigo Complaint Here
Read Nationwide v. Perrigo Motion to Dismiss Opinion Here
Read Principal v. Perrigo Complaint Here
Read Aberdeen v. Perrigo Complaint Here
Read Carmignac Gestion v. Perrigo Complaint Here
Read Carmignac Gestion v. Perrigo Motion to Dismiss Opinion Here